History
2022: Collaboration with Servier to find ways to treat pancreatic cancer
The independent international pharmaceutical company "" Servier on October 5, 2022 announced that, together with the division of the precision medicine the French biopharmaceutical company Oncodesign Precision Medicine (OPM)], they launched scientific a collaboration to find therapeutic targets for therapy. ductal pancreatic adenocarcinoma More. here
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |